Patent · US Active

Compositions of tolperisone

US9315480B2 · kind B2 · utility

2Cited by

6References

10Claims

0Family size

Assignee

SANOCHEMIA PHARMAZEUTIKA AG · AU

Inventors

Federico Gaeta · Carrión de los Condes, ES
Klaus Gerdes · Düsseldorf, DE
Stefan Welzig · Wien, AT
Beate Kalz · Steinbrunn, AT
Jan Rothenburger · Eisenstadt, AT
Jozsef Gungl · Ágfalva, HU

Key dates

Filing date	Apr 24, 2008
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Oct 3, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/145555
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is directed to methods for providing tolperisone having extremely low levels of 4-MMPPO (2-methyl-1-(4-methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.